CASADEI GARDINI, ANDREA
CASADEI GARDINI, ANDREA
Facoltà di Medicina e Chirurgia
1H-NMR based serum metabolomics highlights different specific biomarkers between early and advanced hepatocellular carcinoma stages
2020-01-01 Casadei Gardini, A.; Coco, L. D.; Marisi, G.; Conti, F.; Rovesti, G.; Ulivi, P.; Canale, M.; Frassineti, G. L.; Foschi, F. G.; Longo, S.; Fanizzi, F. P.; Giudetti, A. M.
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index
2021-01-01 Rovesti, G.; Leone, F.; Brandi, G.; Cesario, S.; Scartozzi, M.; Niger, M.; Yoo, C.; Filippi, R.; Casagrande, M.; Silvestris, N.; Santini, D.; Faloppi, L.; Palloni, A.; Aglietta, M.; Bernardini, L.; Cho, H.; Lai, E.; Fenocchio, E.; Pircher, C.; Iacono, D.; De Lorenzo, S.; Sperti, E.; Massa, V.; De Braud, F.; Jeong, J. H.; Aprile, G.; Burgio, V.; Cascinu, S.; Casadei-Gardini, A.
A prognostic model in patients with advanced biliary tract cancer receiving first-line chemotherapy
2021-01-01 Filippi, R; Montagnani, F; Lombardi, P; Fornaro, L; Aprile, G; Casadei-Gardini, A; Faloppi, L; Palloni, A; Satolli, Ma; Scartozzi, M; Citarella, F; Lutrino, Se; Leone, F
Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities
2018-01-01 De Matteis, Serena; Ragusa, Andrea; Marisi, Giorgia; De Domenico, Stefania; Casadei Gardini, Andrea; Bonafè, Massimiliano; Giudetti, Anna Maria
Acute oxaliplatin-induced thrombotic thrombocytopenic purpura: A case report and results from a cytoflourimetric assay of platelet fibrinogen receptor
2013-01-01 Lucchesi, Alessandro; Carloni, Silvia; Cangini, Delia; Frassineti, Giovanni Luca; Casadei Gardini, Andrea
Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib
2021-01-01 Rapposelli, I. G.; Tada, T.; Shimose, S.; Burgio, V.; Kumada, T.; Iwamoto, H.; Hiraoka, A.; Niizeki, T.; Atsukawa, M.; Koga, H.; Hirooka, M.; Torimura, T.; Iavarone, M.; Tortora, R.; Campani, C.; Lonardi, S.; Tamburini, E.; Piscaglia, F.; Masi, G.; Cabibbo, G.; Giuseppe Foschi, F.; Silletta, M.; Tsuji, K.; Ishikawa, T.; Takaguchi, K.; Kariyama, K.; Itobayashi, E.; Tajiri, K.; Shimada, N.; Shibata, H.; Ochi, H.; Yasuda, S.; Toyoda, H.; Fukunishi, S.; Ohama, H.; Kawata, K.; Tani, J.; Nakamura, S.; Nouso, K.; Tsutsui, A.; Nagano, T.; Tanaka, T.; Itokawa, N.; Okubo, T.; Arai, T.; Imai, M.; Joko, K.; Koizumi, Y.; Hiasa, Y.; Rimini, M.; Ratti, F.; Aldrighetti, L.; Cascinu, S.; Casadei-Gardini, A.
Alpha-fetoprotein surge following high-dose chemotherapy in germ cell tumours
2013-01-01 Luca Burgio, Salvatore; Menna, Cecilia; Papiani, Giorgio; Casadei Gardini, Andrea; De Luigi, Nicoletta; Corsi, Roberto; Rosti, Giovanni
Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study
2020-01-01 Faloppi, L.; Puzzoni, M.; Casadei Gardini, A.; Silvestris, N.; Masi, G.; Marisi, G.; Vivaldi, C.; Gadaleta, C. D.; Ziranu, P.; Bianconi, M.; Loretelli, C.; Demurtas, L.; Lai, E.; Giampieri, R.; Galizia, E.; Ulivi, P.; Battelli, N.; Falcone, A.; Cascinu, S.; Scartozzi, M.
ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib
2019-01-01 Marisi, G.; Petracci, E.; Raimondi, F.; Faloppi, L.; Foschi, F. G.; Lauletta, G.; Iavarone, M.; Canale, M.; Valgiusti, M.; Neri, L. M.; Ulivi, P.; Orsi, G.; Rovesti, G.; Vukotic, R.; Conti, F.; Cucchetti, A.; Ercolani, G.; Andrikou, K.; Cascinu, S.; Scartozzi, M.; Casadei-Gardini, A.
Antiangiogenic agents after first line and sorafenib plus chemoembolization: A systematic review
2017-01-01 Casadei Gardini, Andrea; Santini, Daniele; Aprile, Giuseppe; Silvestris, Nicola; Felli, Emanuele; Foschi, Francesco Giuseppe; Ercolani, Giorgio; Marisi, Giorgia; Valgiusti, Martina; Passardi, Alessandro; Puzzoni, Marco; Silletta, Marianna; Brunetti, Oronzo; Cardellino, Giovanni Gerardo; Frassineti, Giovanni Luca; Scartozzi, Mario
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study
2023-01-01 Zeng, Qinghe; Klein, Christophe; Caruso, Stefano; Maille, Pascale; S Allende, Daniela; Mínguez, Beatriz; Iavarone, Massimo; Ningarhari, Massih; Casadei-Gardini, Andrea; Pedica, Federica; Rimini, Margherita; Perbellini, Riccardo; Boulagnon-Rombi, Camille; Heurgué, Alexandra; Maggioni, Marco; Rela, Mohamed; Vij, Mukul; Baulande, Sylvain; Legoix, Patricia; Lameiras, Sonia; study group, theHCC-AI; Bruges, Léa; Gnemmi, Viviane; Nault, Jean-Charles; Campani, Claudia; Rhee, Hyungjin; Nyun Park, Young; Iñarrairaegui, Mercedes; Garcia-Porrero, Guillermo; Argemi, Josepmaria; Sangro, Bruno; D'Alessio, Antonio; Scheiner, Bernhard; James Pinato, David; Pinter, Matthias; Paradis, Valérie; Beaufrère, Aurélie; Peter, Simon; Rimassa, Lorenza; Di Tommaso, Luca; Vogel, Arndt; Michalak, Sophie; Boursier, Jérôme; Loménie, Nicolas; Ziol, Marianne; Calderaro, Julien
Association of NOS3 and ANGPT2 Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE Study
2020-01-01 Casadei Gardini, A; Marisi, G; Dadduzio, V; Gramantieri, L; Faloppi, L; Ulivi, P; Foschi, Fg; Tamburini, E; Vivaldi, C; Rizzato, Md; Ielasi, L; Canale, M; Conti, F; Rudnas, B; Fornaro, L; Silvestris, N; Silletta, M; Cardellino, Gg; Lonardi, S; Fornari, F; Orsi, G; Rovesti, G; Zagonel, V; Cascinu, S; Scartozzi, M
Atezolizumab and bevacizumab in advanced HCC: ready for prime time?
2020-01-01 Casadei-Gardini, A; Cascinu, S; Colombo, M
Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma: Ready for Prime Time?
2021-01-01 Casadei-Gardini, A.; Cascinu, S.; Colombo, M.
Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population
2022-01-01 Casadei-Gardini, Andrea; Rimini, Margherita; Tada, Toshifumi; Suda, Goki; Shimose, Shigeo; Kudo, Masatoshi; Cheon, Jaekyung; Finkelmeier, Fabian; Lim, Ho Yeong; Rimassa, Lorenza; Presa, José; Masi, Gianluca; Yoo, Changhoon; Lonardi, Sara; Tovoli, Francesco; Kumada, Takashi; Sakamoto, Naoya; Iwamoto, Hideki; Aoki, Tomoko; Chon, Hong Jae; Himmelsbach, Vera; Pressiani, Tiziana; Montes, Margarida; Vivaldi, Caterina; Soldà, Caterina; Piscaglia, Fabio; Hiraoka, Atsushi; Sho, Takuya; Niizeki, Takashi; Nishida, Naoshi; Steup, Christoph; Iavarone, Massimo; Di Costanzo, Giovanni; Marra, Fabio; Scartozzi, Mario; Tamburini, Emiliano; Cabibbo, Giuseppe; Foschi, Francesco Giuseppe; Silletta, Marianna; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Ochi, Hironori; Yasuda, Satoshi; Toyoda, Hidenori; Ogawa, Chikara; Nishimura, Takashi; Hatanaka, Takeshi; Kakizaki, Satoru; Shimada, Noritomo; Kawata, Kazuhito; Tada, Fujimasa; Ohama, Hideko; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Imai, Michitaka; Kosaka, Hisashi; Naganuma, Atsushi; Koizumi, Yohei; Nakamura, Shinichiro; Kaibori, Masaki; Iijima, Hiroko; Hiasa, Yoichi; Burgio, Valentina; Persano, Mara; Della Corte, Angelo; Ratti, Francesca; De Cobelli, Francesco; Aldrighetti, Luca; Cascinu, Stefano; Cucchetti, Alessandro
Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis
2022-01-01 Rimini, M; Rimassa, L; Ueshima, K; Burgio, V; Shigeo, S; Tada, T; Suda, G; Yoo, C; Cheon, J; Pinato, D J; Lonardi, S; Scartozzi, M; Iavarone, M; Di Costanzo, G G; Marra, F; Soldà, C; Tamburini, E; Piscaglia, F; Masi, G; Cabibbo, G; Foschi, F G; Silletta, M; Pressiani, T; Nishida, N; Iwamoto, H; Sakamoto, N; Ryoo, B-Y; Chon, H J; Claudia, F; Niizeki, T; Sho, T; Kang, B; D'Alessio, A; Kumada, T; Hiraoka, A; Hirooka, M; Kariyama, K; Tani, J; Atsukawa, M; Takaguchi, K; Itobayashi, E; Fukunishi, S; Tsuji, K; Ishikawa, T; Tajiri, K; Ochi, H; Yasuda, S; Toyoda, H; Ogawa, C; Nishimur, T; Hatanaka, T; Kakizaki, S; Shimada, N; Kawata, K; Tanaka, T; Ohama, H; Nouso, K; Morishita, A; Tsutsui, A; Nagano, T; Itokawa, N; Okubo, T; Arai, T; Imai, M; Naganuma, A; Koizumi, Y; Nakamura, S; Joko, K; Iijima, H; Hiasa, Y; Pedica, F; De Cobelli, F; Ratti, F; Alrighetti, L; Kudo, M; Cascinu, S; Casadei-Gardini, A
Atypical presentations of thrombotic thrombocytopenic purpura in middle-aged women with recurrent cerebral macrovascular thrombosis: a case report
2015-01-01 Lucchesi, Alessandro; Fattori, Pier Paolo; Ronconi, Sonia; Carloni, Silvia; Casadei Gardini, Andrea; Musuraca, Gerardo; Napolitano, Mariasanta
Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study
2012-01-01 Clavarezza, Matteo; Mustacchi, Giorgio; Casadei Gardini, Andrea; Del Mastro, Lucia; De Matteis, Andrea; Riccardi, Ferdinando; Adamo, Vincenzo; Aitini, Enrico; Amoroso, Domenico; Marchetti, Paolo; Gori, Stefania; Carrozza, Francesco; Maiello, Evaristo; Giotta, Francesco; Dondi, Davide; Venturini, Marco
BRAF-mutated colorectal cancer: Clinical and molecular insights
2019-01-01 Caputo, F.; Santini, C.; Bardasi, C.; Cerma, K.; Casadei-Gardini, A.; Spallanzani, A.; Andrikou, K.; Cascinu, S.; Gelsomino, F.
BRCA in gastrointestinal cancers: Current treatments and future perspectives
2020-01-01 Molinaro, E.; Andrikou, K.; Casadei Gardini, A.; Rovesti, G.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
1H-NMR based serum metabolomics highlights different specific biomarkers between early and advanced hepatocellular carcinoma stages | 1-gen-2020 | Casadei Gardini, A.; Coco, L. D.; Marisi, G.; Conti, F.; Rovesti, G.; Ulivi, P.; Canale, M.; Frassineti, G. L.; Foschi, F. G.; Longo, S.; Fanizzi, F. P.; Giudetti, A. M. | |
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index | 1-gen-2021 | Rovesti, G.; Leone, F.; Brandi, G.; Cesario, S.; Scartozzi, M.; Niger, M.; Yoo, C.; Filippi, R.; Casagrande, M.; Silvestris, N.; Santini, D.; Faloppi, L.; Palloni, A.; Aglietta, M.; Bernardini, L.; Cho, H.; Lai, E.; Fenocchio, E.; Pircher, C.; Iacono, D.; De Lorenzo, S.; Sperti, E.; Massa, V.; De Braud, F.; Jeong, J. H.; Aprile, G.; Burgio, V.; Cascinu, S.; Casadei-Gardini, A. | |
A prognostic model in patients with advanced biliary tract cancer receiving first-line chemotherapy | 1-gen-2021 | Filippi, R; Montagnani, F; Lombardi, P; Fornaro, L; Aprile, G; Casadei-Gardini, A; Faloppi, L; Palloni, A; Satolli, Ma; Scartozzi, M; Citarella, F; Lutrino, Se; Leone, F | |
Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities | 1-gen-2018 | De Matteis, Serena; Ragusa, Andrea; Marisi, Giorgia; De Domenico, Stefania; Casadei Gardini, Andrea; Bonafè, Massimiliano; Giudetti, Anna Maria | |
Acute oxaliplatin-induced thrombotic thrombocytopenic purpura: A case report and results from a cytoflourimetric assay of platelet fibrinogen receptor | 1-gen-2013 | Lucchesi, Alessandro; Carloni, Silvia; Cangini, Delia; Frassineti, Giovanni Luca; Casadei Gardini, Andrea | |
Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib | 1-gen-2021 | Rapposelli, I. G.; Tada, T.; Shimose, S.; Burgio, V.; Kumada, T.; Iwamoto, H.; Hiraoka, A.; Niizeki, T.; Atsukawa, M.; Koga, H.; Hirooka, M.; Torimura, T.; Iavarone, M.; Tortora, R.; Campani, C.; Lonardi, S.; Tamburini, E.; Piscaglia, F.; Masi, G.; Cabibbo, G.; Giuseppe Foschi, F.; Silletta, M.; Tsuji, K.; Ishikawa, T.; Takaguchi, K.; Kariyama, K.; Itobayashi, E.; Tajiri, K.; Shimada, N.; Shibata, H.; Ochi, H.; Yasuda, S.; Toyoda, H.; Fukunishi, S.; Ohama, H.; Kawata, K.; Tani, J.; Nakamura, S.; Nouso, K.; Tsutsui, A.; Nagano, T.; Tanaka, T.; Itokawa, N.; Okubo, T.; Arai, T.; Imai, M.; Joko, K.; Koizumi, Y.; Hiasa, Y.; Rimini, M.; Ratti, F.; Aldrighetti, L.; Cascinu, S.; Casadei-Gardini, A. | |
Alpha-fetoprotein surge following high-dose chemotherapy in germ cell tumours | 1-gen-2013 | Luca Burgio, Salvatore; Menna, Cecilia; Papiani, Giorgio; Casadei Gardini, Andrea; De Luigi, Nicoletta; Corsi, Roberto; Rosti, Giovanni | |
Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study | 1-gen-2020 | Faloppi, L.; Puzzoni, M.; Casadei Gardini, A.; Silvestris, N.; Masi, G.; Marisi, G.; Vivaldi, C.; Gadaleta, C. D.; Ziranu, P.; Bianconi, M.; Loretelli, C.; Demurtas, L.; Lai, E.; Giampieri, R.; Galizia, E.; Ulivi, P.; Battelli, N.; Falcone, A.; Cascinu, S.; Scartozzi, M. | |
ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib | 1-gen-2019 | Marisi, G.; Petracci, E.; Raimondi, F.; Faloppi, L.; Foschi, F. G.; Lauletta, G.; Iavarone, M.; Canale, M.; Valgiusti, M.; Neri, L. M.; Ulivi, P.; Orsi, G.; Rovesti, G.; Vukotic, R.; Conti, F.; Cucchetti, A.; Ercolani, G.; Andrikou, K.; Cascinu, S.; Scartozzi, M.; Casadei-Gardini, A. | |
Antiangiogenic agents after first line and sorafenib plus chemoembolization: A systematic review | 1-gen-2017 | Casadei Gardini, Andrea; Santini, Daniele; Aprile, Giuseppe; Silvestris, Nicola; Felli, Emanuele; Foschi, Francesco Giuseppe; Ercolani, Giorgio; Marisi, Giorgia; Valgiusti, Martina; Passardi, Alessandro; Puzzoni, Marco; Silletta, Marianna; Brunetti, Oronzo; Cardellino, Giovanni Gerardo; Frassineti, Giovanni Luca; Scartozzi, Mario | |
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study | 1-gen-2023 | Zeng, Qinghe; Klein, Christophe; Caruso, Stefano; Maille, Pascale; S Allende, Daniela; Mínguez, Beatriz; Iavarone, Massimo; Ningarhari, Massih; Casadei-Gardini, Andrea; Pedica, Federica; Rimini, Margherita; Perbellini, Riccardo; Boulagnon-Rombi, Camille; Heurgué, Alexandra; Maggioni, Marco; Rela, Mohamed; Vij, Mukul; Baulande, Sylvain; Legoix, Patricia; Lameiras, Sonia; study group, theHCC-AI; Bruges, Léa; Gnemmi, Viviane; Nault, Jean-Charles; Campani, Claudia; Rhee, Hyungjin; Nyun Park, Young; Iñarrairaegui, Mercedes; Garcia-Porrero, Guillermo; Argemi, Josepmaria; Sangro, Bruno; D'Alessio, Antonio; Scheiner, Bernhard; James Pinato, David; Pinter, Matthias; Paradis, Valérie; Beaufrère, Aurélie; Peter, Simon; Rimassa, Lorenza; Di Tommaso, Luca; Vogel, Arndt; Michalak, Sophie; Boursier, Jérôme; Loménie, Nicolas; Ziol, Marianne; Calderaro, Julien | |
Association of NOS3 and ANGPT2 Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE Study | 1-gen-2020 | Casadei Gardini, A; Marisi, G; Dadduzio, V; Gramantieri, L; Faloppi, L; Ulivi, P; Foschi, Fg; Tamburini, E; Vivaldi, C; Rizzato, Md; Ielasi, L; Canale, M; Conti, F; Rudnas, B; Fornaro, L; Silvestris, N; Silletta, M; Cardellino, Gg; Lonardi, S; Fornari, F; Orsi, G; Rovesti, G; Zagonel, V; Cascinu, S; Scartozzi, M | |
Atezolizumab and bevacizumab in advanced HCC: ready for prime time? | 1-gen-2020 | Casadei-Gardini, A; Cascinu, S; Colombo, M | |
Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma: Ready for Prime Time? | 1-gen-2021 | Casadei-Gardini, A.; Cascinu, S.; Colombo, M. | |
Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population | 1-gen-2022 | Casadei-Gardini, Andrea; Rimini, Margherita; Tada, Toshifumi; Suda, Goki; Shimose, Shigeo; Kudo, Masatoshi; Cheon, Jaekyung; Finkelmeier, Fabian; Lim, Ho Yeong; Rimassa, Lorenza; Presa, José; Masi, Gianluca; Yoo, Changhoon; Lonardi, Sara; Tovoli, Francesco; Kumada, Takashi; Sakamoto, Naoya; Iwamoto, Hideki; Aoki, Tomoko; Chon, Hong Jae; Himmelsbach, Vera; Pressiani, Tiziana; Montes, Margarida; Vivaldi, Caterina; Soldà, Caterina; Piscaglia, Fabio; Hiraoka, Atsushi; Sho, Takuya; Niizeki, Takashi; Nishida, Naoshi; Steup, Christoph; Iavarone, Massimo; Di Costanzo, Giovanni; Marra, Fabio; Scartozzi, Mario; Tamburini, Emiliano; Cabibbo, Giuseppe; Foschi, Francesco Giuseppe; Silletta, Marianna; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Ochi, Hironori; Yasuda, Satoshi; Toyoda, Hidenori; Ogawa, Chikara; Nishimura, Takashi; Hatanaka, Takeshi; Kakizaki, Satoru; Shimada, Noritomo; Kawata, Kazuhito; Tada, Fujimasa; Ohama, Hideko; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Imai, Michitaka; Kosaka, Hisashi; Naganuma, Atsushi; Koizumi, Yohei; Nakamura, Shinichiro; Kaibori, Masaki; Iijima, Hiroko; Hiasa, Yoichi; Burgio, Valentina; Persano, Mara; Della Corte, Angelo; Ratti, Francesca; De Cobelli, Francesco; Aldrighetti, Luca; Cascinu, Stefano; Cucchetti, Alessandro | |
Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis | 1-gen-2022 | Rimini, M; Rimassa, L; Ueshima, K; Burgio, V; Shigeo, S; Tada, T; Suda, G; Yoo, C; Cheon, J; Pinato, D J; Lonardi, S; Scartozzi, M; Iavarone, M; Di Costanzo, G G; Marra, F; Soldà, C; Tamburini, E; Piscaglia, F; Masi, G; Cabibbo, G; Foschi, F G; Silletta, M; Pressiani, T; Nishida, N; Iwamoto, H; Sakamoto, N; Ryoo, B-Y; Chon, H J; Claudia, F; Niizeki, T; Sho, T; Kang, B; D'Alessio, A; Kumada, T; Hiraoka, A; Hirooka, M; Kariyama, K; Tani, J; Atsukawa, M; Takaguchi, K; Itobayashi, E; Fukunishi, S; Tsuji, K; Ishikawa, T; Tajiri, K; Ochi, H; Yasuda, S; Toyoda, H; Ogawa, C; Nishimur, T; Hatanaka, T; Kakizaki, S; Shimada, N; Kawata, K; Tanaka, T; Ohama, H; Nouso, K; Morishita, A; Tsutsui, A; Nagano, T; Itokawa, N; Okubo, T; Arai, T; Imai, M; Naganuma, A; Koizumi, Y; Nakamura, S; Joko, K; Iijima, H; Hiasa, Y; Pedica, F; De Cobelli, F; Ratti, F; Alrighetti, L; Kudo, M; Cascinu, S; Casadei-Gardini, A | |
Atypical presentations of thrombotic thrombocytopenic purpura in middle-aged women with recurrent cerebral macrovascular thrombosis: a case report | 1-gen-2015 | Lucchesi, Alessandro; Fattori, Pier Paolo; Ronconi, Sonia; Carloni, Silvia; Casadei Gardini, Andrea; Musuraca, Gerardo; Napolitano, Mariasanta | |
Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study | 1-gen-2012 | Clavarezza, Matteo; Mustacchi, Giorgio; Casadei Gardini, Andrea; Del Mastro, Lucia; De Matteis, Andrea; Riccardi, Ferdinando; Adamo, Vincenzo; Aitini, Enrico; Amoroso, Domenico; Marchetti, Paolo; Gori, Stefania; Carrozza, Francesco; Maiello, Evaristo; Giotta, Francesco; Dondi, Davide; Venturini, Marco | |
BRAF-mutated colorectal cancer: Clinical and molecular insights | 1-gen-2019 | Caputo, F.; Santini, C.; Bardasi, C.; Cerma, K.; Casadei-Gardini, A.; Spallanzani, A.; Andrikou, K.; Cascinu, S.; Gelsomino, F. | |
BRCA in gastrointestinal cancers: Current treatments and future perspectives | 1-gen-2020 | Molinaro, E.; Andrikou, K.; Casadei Gardini, A.; Rovesti, G. |